- Home
- WOR vs CPRX Comparison
WOR vs CPRX Comparison
Compare WOR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WOR | CPRX |
|---|---|---|
| Founded | 1955 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | WOR | CPRX |
|---|---|---|
| Price | $54.97 | $22.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $61.00 | $32.60 |
| AVG Volume (30 Days) | 144.5K | ★ 1.4M |
| Earning Date | 12-16-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 179.34 | 44.94 |
| EPS | ★ 2.14 | 1.71 |
| Revenue | ★ $1,200,161,000.00 | $578,196,000.00 |
| Revenue This Year | $14.93 | $16.59 |
| Revenue Next Year | $4.45 | $8.42 |
| P/E Ratio | $25.64 | ★ $13.26 |
| Revenue Growth | 0.76 | ★ 25.56 |
| 52 Week Low | $37.88 | $19.05 |
| 52 Week High | $70.91 | $26.58 |
Technical Indicators
Market Signals| Indicator | WOR | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 54.15 |
| Support Level | $52.44 | $23.01 |
| Resistance Level | $56.33 | $23.92 |
| Average True Range (ATR) | 1.25 | 0.69 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 68.59 | 47.29 |
Price Performance
Historical ComparisonAbout WOR Worthington Enterprises Inc.
Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).